The FDA’s approval of new COVID-19 vaccines targeting the KP.2 strain comes amidst concerns about waning immunity and evolving virus variants.

Food allergies affect 33 million Americans, with 150 deaths annually from food-related allergic reactions in the US, emphasizing the critical need for stringent allergen management in public dining establishments.

Recent data shows a significant increase in pulmonary vein isolation procedures for atrial fibrillation among older adults, with concurrent decreases in complication and hospitalization rates.

The CDC reports “very high” COVID-19 levels in 32 states, with two new Omicron variants accounting for more than half of all US cases.

Researchers report that consuming more than 400 milligrams of caffeine per day can increase a person’s risk of cardiovascular disease.

The introduction of lisdexamfetamine, a generic for Vyvanse, initially showed promise in increasing access to ADHD treatment. However, it too has fallen into shortage, highlighting the ongoing challenges in meeting patient demand.